For 16 years, Sarah Stella, MD, has been caring for patients as an internal medicine hospitalist at Denver Health, Denver’s primary safety-net institution.
“I have always loved caring for all my patients, but especially those experiencing homelessness. I wanted to understand what was happening to them after they left my care in the hospital and how I could better help” said Stella, who is also an associate professor of medicine at the University of Colorado School of Medicine.
Dear CCTSI research community,
The days are getting longer, spring is officially here and there is much to look forward to.
Registration is open for several of our short courses developed specifically for researchers, including Communicating Your Science to the Public. Uniquely tailored mock study section grant review opportunities are available such as the Pre-K and Pre-R grant review sessions. LOIs are due April 8 and April 4 respectively. Our brand new Pre-F program helps students and postdocs prepare and submit successful applications to the NIH for their individual NRSA (F30, F31, F32) fellowships. Applications are due May 15. We are offering a “Tips and Tricks” Fellowship Seminar offering a practical guide to NRSA Fellowship applications on May 3.
On November 2, Matthew DeCamp, MD, associate professor in the Center for Bioethics and Humanities, warmly welcomed the 105 participants to the 13th Annual CCTSI Research Ethics Conference. The event, which took place in person at the Fulginiti Pavilion and virtually via Zoom, attracted faculty, staff, researchers and students from across the country for an engaging and informative session.
Everyone might be tired of hearing about COVID-19, but the fact is that Colorado’s long COVID clinics can’t meet the demand. Up to 500,000 Coloradans continue to experience long-term symptoms after COVID, or so-called long COVID. To address this issue, a group of health care providers, researchers and patient advocates came together for a roundtable discussion on long COVID care on Nov. 29 with Colorado’s Lt. Gov. Dianne Primavera.
Research Community and Practice ColoradoSPH at CU Anschutz CCTSI
Imagine you have conducted a study and want to tell the world about the findings. Or suppose your research results show great promise for a particular cancer treatment, and now you need to make sure caregivers understand the impact of your work. What do you do? If you attended the recent CU-CSU Summit, you might have some ideas!
Research Press Releases Funding CCTSI
The National Institutes of Health has awarded $54 million over a seven-year period to the CCTSI at CU Anschutz. The grant from the National Center for Advancing Translational Sciences (NCATS) will fuel biomedical research and training across the state. This is the fourth consecutive time the NIH has funded the CCTSI since 2008 through its Clinical Translational Science Award (CTSA) program.
Addiction Community and Practice CCTSI
Scott Simpson, MD, MPH, is an emergency psychiatrist at Denver Health Medical Center and an associate professor of psychiatry in the University of Colorado School of Medicine. Several years ago, he and his colleagues were working with the Denver Police Department to expand the use of suboxone treatment for individuals with opioid use disorder.
Have you heard about a horse tranquilizer that rots flesh? A fungus that spreads between people? How do you know what is true? Should you be concerned or take any action?
A 15-year, multicenter study has changed the course of care for youth with type 2 diabetes, enhancing treatments for this growing population and illustrating the scope of the work conducted on the CU Anschutz Medical Campus. Called Treatment Options for Type 2 Diabetes in Adolescents & Youth (TODAY), the massive clinical trial included 699 participants and was led nationally by Phil Zeitler, MD, professor, pediatrics-endocrinology, University of Colorado School of Medicine.
This month, Barbara Hammack, PhD is retiring after dedicating 23 years to clinical research at the University of Colorado Anschutz Medical Campus. After receiving her PhD in theoretical biophysics, she took a fellowship in the Department of Neurology, investigating Multiple Sclerosis and its causes. A few years later, she worked on studies related to amyotrophic lateral sclerosis (ALS) and complications from shingles.
Research Press Releases COVID-19 CCTSI
Though many Coloradans are proceeding as though the COVID-19 pandemic is over, the virus continues to circulate, evolve and have an impact—especially for older adults and those with underlying medical conditions. Furthermore, because of the evolution of variants, doctors have fewer treatment options.
Ronald J. Sokol, MD has been named a University of Colorado Distinguished Professor. Distinguished Professor is a title signifying the highest honor awarded to faculty across the CU system’s four campuses. CU Distinguished Professors are tenured faculty members who demonstrate exemplary performance in research or creative work; a record of excellence in promoting learning and student attainment of knowledge and skills; and outstanding service to the profession, the university and its affiliates.
Research Genetics CCTSI rare disease
You probably learned about cilia in high school biology class. The tiny hairlike structures line our nasal passages, ears and airways. Children born with primary ciliary dyskinesia (PCD), a rare inherited disease, have problems with the cilia that prevent them from moving mucus and inhaled particles and germs out of their airways, causing mucus to build up, leading to ear, sinus and lung infections.
Clinical Research Geriatrics CCTSI
Clinical research is one of the primary reasons the University of Colorado Anschutz Medical Campus is a nationally renowned healthcare destination. Yet in 2019, only 25% of CU Anschutz adult clinical trials enrolled even one participant over age 50. Study results may not apply to unrepresented populations, so the National Institutes of Health (NIH) requires clinical research to include individuals across the life span.
The Colorado Sun
March 28, 2024
Researchers at National Jewish Health conducted some of the earliest studies on using anti-IgE drugs to prevent severe allergic reactions to food
Reuters
March 05, 2024
The study was conducted at the CCTSI's Clinical Translational Research Center.
Health Affairs
February 29, 2024
CCTSI's pilot awardee's project helps launch Denver program that links care, services and housing.
The Conversation
February 21, 2024
The Conversation US asked Dr. Jacob Pellinen, a neurologist specializing in epilepsy, to walk us through how to recognize a seizure in a bystander or loved one and what to do in those crucial moments after a seizure begins. Research is supported by the Colorado Clinical and Translational Sciences Institute.
Wendy Meyer
